Use of ibuprofen in the context of the SARS-CoV-2 pandemic
A few months after the onset of the 2019 coronavirus disease pandemic (COVID-19), it has been suggested that the use of certain nonsteroidal anti-inflammatory drugs may increase the severity and mortality of the disease, therefore it should be avoided in those who become ill. The hypothesis was base...
Main Authors: | Octavia Sabin, Anca Dana Buzoianu |
---|---|
Format: | Article |
Language: | English |
Published: |
Amaltea Medical Publishing House
2020-09-01
|
Series: | Romanian Medical Journal |
Subjects: | |
Online Access: | https://rmj.com.ro/articles/2020.3/RMJ_2020_3_Art-04.pdf |
Similar Items
-
Blocking the action of NLRP3 inflammasome by inhaled ibuprofenate on pulmonary macrophages infected by SARS‐CoV‐2
by: Christian Carlos Zurita‐Lizza, et al.
Published: (2023-02-01) -
Repurposing Inhaled Ibuprofenate, a Non Steroidal Anti‐Inflammatory Drug, as a Potential Adjuvant Treatment for Pneumonia, CARDS and its Aetiological Agent SARS‐CoV‐2
by: Christian Carlos Zurita‐Lizza, et al.
Published: (2023-06-01) -
Methodology for assessing herd immunity to the SARS-CoV-2 virus in the context of the COVID-19 pandemic
by: A. Yu. Popova, et al.
Published: (2021-09-01) -
Safe use of ibuprofen in COVID-19 in children
by: T.P. Borysova
Published: (2022-03-01) -
A Review of SARS-CoV2: Compared With SARS-CoV and MERS-CoV
by: Huan Zhou, et al.
Published: (2021-12-01)